As European markets navigate cautious optimism amid geopolitical developments and mixed economic indicators, investors are keenly observing undervalued opportunities in the region. Identifying stocks trading at significant discounts can offer potential value, especially when market conditions present a blend of challenges and prospects for growth. Top 10 Undervalued Stocks Based On Cash Flows In Europe Name Current Price Fair Value (Est) Discount (Est) Vimi Fasteners (BIT:VIM) €0.995 €1.95 48.9% Wienerberger (WBAG:WIE) €33.62 €67.13 49.9% CD Projekt (WSE:CDR) PLN222.90 PLN441.95 49.6% Vestas Wind Systems (CPSE:VWS) DKK104.05 DKK205.07 49.3% Nyab (OM:NYAB) SEK5.27 SEK10.42 49.4% Cint Group (OM:CINT) SEK6.67 SEK13.22 49.5% Surgical Science Sweden (OM:SUS) SEK159.00 SEK310.42 48.8% Groupe Airwell Société anonyme (ENXTPA:ALAIR) €1.24 €2.42 48.7% Bactiguard Holding (OM:BACTI B) SEK34.80 SEK68.97 49.5% Facephi Biometria (BME:FACE) €2.07 €4.04 48.7% Click here to see the full list of 201 stocks from our Undervalued European Stocks Based On Cash Flows screener. Underneath we present a selection of stocks filtered out by our screen. CVC Capital Partners Overview: CVC Capital Partners plc is a private equity and venture capital firm that focuses on middle market secondaries, infrastructure, credit, management buyouts, leveraged buyouts, growth equity, mature investments, recapitalizations, strip sales and spinouts with a market cap of €24.61 billion. Operations: CVC Capital Partners plc generates revenue through its focus on middle market secondaries, infrastructure and credit investments, management and leveraged buyouts, growth equity, mature investments, recapitalizations, strip sales and spinouts. Estimated Discount To Fair Value: 11.6% CVC Capital Partners is trading at €23.15, slightly below its estimated fair value of €26.2, representing an 11.6% discount. Despite carrying a high level of debt, CVC's earnings are forecast to grow significantly at 27.4% annually over the next three years, outpacing the Dutch market's growth rate of 12.6%. Recent M&A activity includes interest in Akzo Nobel’s South Asia portfolio and divesting a stake in HealthCare Global Enterprises to KKR & Co., potentially impacting future cash flows positively. The analysis detailed in our CVC Capital Partners growth report hints at robust future financial performance. Click to explore a detailed breakdown of our findings in CVC Capital Partners' balance sheet health report.ENXTAM:CVC Discounted Cash Flow as at Feb 2025 Just Eat Takeaway.com Overview: Just Eat Takeaway.com N.V. operates as a global online food delivery company with a market cap of approximately €3.92 billion. Story Continues Operations: The company's revenue segments include North America (€1.97 billion), UK and Ireland (€1.39 billion), Northern Europe (€1.37 billion), and Southern Europe & Australia (€372 million). Estimated Discount To Fair Value: 45.2% Just Eat Takeaway.com is trading at €19.37, significantly below its estimated fair value of €35.36, indicating it is undervalued based on cash flows. Despite a net loss of €1.64 billion in 2024, the company is expected to become profitable within three years with earnings growth forecasted at over 105% annually. The recent acquisition proposal by Prosus for approximately €4.1 billion underscores potential long-term value under private ownership and strategic realignment post-delistings. Our earnings growth report unveils the potential for significant increases in Just Eat Takeaway.com's future results. Click here and access our complete balance sheet health report to understand the dynamics of Just Eat Takeaway.com.ENXTAM:TKWY Discounted Cash Flow as at Feb 2025 Icade Overview: Icade is a full-service real estate company operating throughout France, specializing in commercial property investment with a portfolio worth €6.8 billion and property development generating €1.3 billion in economic revenue for 2023, with a market capitalization of approximately €1.69 billion. Operations: The company's revenue segments include €1.21 billion from the Property Development Business and €375.60 million from Commercial Property Investment for 2023. Estimated Discount To Fair Value: 17.7% Icade is trading at €22.24, below its estimated fair value of €27.02, suggesting undervaluation based on cash flows. Despite a net loss of €275.9 million in 2024, the company is expected to achieve profitability within three years with earnings growth forecasted at 83% annually. Revenue growth is anticipated to outpace the French market, yet its high dividend yield remains unsustainable due to insufficient coverage by earnings or free cash flows. Our comprehensive growth report raises the possibility that Icade is poised for substantial financial growth. Take a closer look at Icade's balance sheet health here in our report.ENXTPA:ICAD Discounted Cash Flow as at Feb 2025 Summing It All Up Unlock our comprehensive list of 201 Undervalued European Stocks Based On Cash Flows by clicking here. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets. Seeking Other Investments? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTAM:CVC ENXTAM:TKWY and ENXTPA:ICAD. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
3 European Stocks Estimated To Be Trading At Discounts Of Up To 45.2%
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...